91 related articles for article (PubMed ID: 21517272)
41. Spatial analysis of incidence of cutaneous melanoma in the Friuli Venezia Giulia region in the period 1995-2005.
Cecconi L; Busolin A; Barbone F; Serraino D; Chiarugi A; Biggeri A; Catelan D
Geospat Health; 2016 Apr; 11(1):422. PubMed ID: 27087039
[TBL] [Abstract][Full Text] [Related]
42. Cutaneous malignant melanoma in children and adolescents in Sweden, 1993-2002: the increasing trend is broken.
Karlsson PM; Fredrikson M
Int J Cancer; 2007 Jul; 121(2):323-8. PubMed ID: 17372908
[TBL] [Abstract][Full Text] [Related]
43. Incidence and current trends of colorectal malignancies in an unscreened, low risk Pakistan population.
Bhurgri Y; Khan T; Kayani N; Ahmad R; Usman A; Bhurgri A; Bashir I; Hasan SH; Zaidi S
Asian Pac J Cancer Prev; 2011; 12(3):703-8. PubMed ID: 21627368
[TBL] [Abstract][Full Text] [Related]
44. Invasive cutaneous melanoma in The Netherlands, 1989-1990.
Tersmette AC; Coebergh JW; Casparie-van Velsen IJ; Ruiter DJ; van der Rhee HJ; Welvaart K
Eur J Cancer Prev; 1996 Feb; 5(1):69-74. PubMed ID: 8664813
[TBL] [Abstract][Full Text] [Related]
45. Increasing time trends of thin melanomas in The Netherlands: What are the explanations of recent accelerations?
van der Leest RJ; Zoutendijk J; Nijsten T; Mooi WJ; van der Rhee JI; de Vries E; Hollestein LM
Eur J Cancer; 2015 Dec; 51(18):2833-41. PubMed ID: 26589973
[TBL] [Abstract][Full Text] [Related]
46. Incidence of cutaneous malignant melanoma in the Ottawa region: 1996 to 2006.
Nevins T; Su Y; Doucette S; Kanigsberg N
J Cutan Med Surg; 2008; 12(6):276-81. PubMed ID: 19317949
[TBL] [Abstract][Full Text] [Related]
47. Cutaneous melanoma in the Maltese Islands: 2000-2004.
Dalmas M; England K; Boffa MJ; Degaetano J; Gatt P
Eur J Cancer; 2007 Jul; 43(10):1604-10. PubMed ID: 17532206
[TBL] [Abstract][Full Text] [Related]
48. Pattern of malignant bone tumour in northern areas of Pakistan.
Ahmad M; Ghani A; Mansoor A; Khan AH
J Pak Med Assoc; 1994 Sep; 44(9):203-5. PubMed ID: 7799506
[TBL] [Abstract][Full Text] [Related]
49. Problems in assessing multiple cutaneous melanoma. A review on the accuracy of a population based cancer registry.
Måsbäck A; Andersson G; Olsson H
Cancer Epidemiol; 2010 Jun; 34(3):262-6. PubMed ID: 20346747
[TBL] [Abstract][Full Text] [Related]
50. [Clinical epidemiologic data of malignant melanoma based on 1,368 patients of the Graz University Dermatology Clinic (1970-1989)].
Rieger E; Soyer HP; Kofler R; Hödl S; Smolle J; Richtig E; Kerl H
Wien Klin Wochenschr; 1991; 103(20):612-6. PubMed ID: 1763507
[TBL] [Abstract][Full Text] [Related]
51. Laboratory profile in patients of cutaneous leishmaniasis from various regions of Pakistan.
Rahman Sb; Bari Au
J Coll Physicians Surg Pak; 2003 Jun; 13(6):313-6. PubMed ID: 12814526
[TBL] [Abstract][Full Text] [Related]
52. Inducible nitric oxide synthase expression in benign and malignant cutaneous melanocytic lesions.
Massi D; Franchi A; Sardi I; Magnelli L; Paglierani M; Borgognoni L; Maria Reali U; Santucci M
J Pathol; 2001 Jun; 194(2):194-200. PubMed ID: 11400148
[TBL] [Abstract][Full Text] [Related]
53. Opportunistic screening strategy for cutaneous melanoma does not change the incidence of nodular and thick lesions nor reduce mortality: a population-based descriptive study in the European region with the highest incidence.
Bordoni A; Leoni-Parvex S; Peverelli S; Mazzola P; Mazzucchelli L; Spitale A
Melanoma Res; 2013 Oct; 23(5):402-7. PubMed ID: 23839077
[TBL] [Abstract][Full Text] [Related]
54. Morphological profile and association of HER-2/neu with prognostic markers in breast carcinoma in Northern Pakistan.
Sharif MA; Mamoon N; Mushtaq S; Khadim MT
J Coll Physicians Surg Pak; 2009 Feb; 19(2):99-103. PubMed ID: 19208313
[TBL] [Abstract][Full Text] [Related]
55. Steroid hormone receptor association with prognostic markers in breast carcinoma in Northern Pakistan.
Sharif MA; Mamoon N; Mushtaq S; Khadim MT; Jamal S
J Coll Physicians Surg Pak; 2010 Mar; 20(3):181-5. PubMed ID: 20392381
[TBL] [Abstract][Full Text] [Related]
56. Prognostic factors for cutaneous malignant melanoma in Vaud, Switzerland.
Levi F; Randimbison L; La Vecchia C; Te VC; Franceschi S
Int J Cancer; 1998 Oct; 78(3):315-9. PubMed ID: 9766565
[TBL] [Abstract][Full Text] [Related]
57. Sex differences in rising trends of cutaneous malignant melanoma in Norway, 1954-2008.
Robsahm TE; Bergva G; Hestvik UE; Møller B
Melanoma Res; 2013 Feb; 23(1):70-8. PubMed ID: 23222548
[TBL] [Abstract][Full Text] [Related]
58. Clinical characteristics, management and survival in young adults diagnosed with malignant melanoma: A population-based cohort study.
Plym A; Ullenhag GJ; Breivald M; Lambe M; Berglund A
Acta Oncol; 2014 May; 53(5):688-96. PubMed ID: 24369746
[TBL] [Abstract][Full Text] [Related]
59. Changes from mid-1980s to late 1990s among clinical and demographic correlates of melanoma thickness.
Crocetti E; Carli P
Eur J Dermatol; 2003; 13(1):72-5. PubMed ID: 12609787
[TBL] [Abstract][Full Text] [Related]
60. Seasonality of cutaneous melanoma diagnoses: a comprehensive comparison of results in Bavaria and Northern Ireland.
Keller AK; Uter W; Pfahlberg AB; Radespiel-Tröger M; Gefeller O
Melanoma Res; 2013 Aug; 23(4):321-30. PubMed ID: 23629624
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
